TECON BIOLOGY Co.LTD (SHE:002100)
China · Delayed Price · Currency is CNY 6.73
+0.21 (3.22%)
Jul 15, 2026, 9:55 AM CST
TECON BIOLOGY Co.LTD Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, TECON BIOLOGY Co.LTD stock has a consensus rating of "Strong Buy" and an average price target of ¥8.15. The average 1-year stock price forecast is 21.10% higher than the current stock price, while the lowest is ¥7.20 (+6.98%) and the highest is ¥10.00 (+48.59%).
Price Target: ¥8.15 (+21.10%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TECON BIOLOGY Co.LTD stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 4 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 5 | 5 | 6 |
Financial Forecast
Revenue This Year
16.53B
from 16.98B
Decreased by -2.68%
Revenue Next Year
19.12B
from 16.53B
Increased by 15.70%
EPS This Year
0.02
EPS Next Year
0.97
from 0.02
Increased by 4,750.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.1B | ||
| Avg | 16.5B | ||
| Low | 15.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.0% | ||
| Avg | -2.7% | ||
| Low | -6.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.02 | ||
| Avg | 0.02 | ||
| Low | 0.02 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -95.1% | ||
| Avg | -95.1% | ||
| Low | -95.1% |